{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T17:29:33Z","timestamp":1747330173702},"reference-count":34,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.3892\/or.2015.3807","type":"journal-article","created":{"date-parts":[[2015,2,16]],"date-time":"2015-02-16T07:47:40Z","timestamp":1424072860000},"page":"1791-1798","source":"Crossref","is-referenced-by-count":10,"title":["Adenovirus-mediated LRIG1 expression enhances the chemosensitivity of bladder cancer cells to cisplatin"],"prefix":"10.3892","volume":"33","author":[{"given":"ZEJUN","family":"YAN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JUNHUI","family":"JIANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FAN","family":"LI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WEIMING","family":"YANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GUOHAI","family":"XIE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CHENG","family":"ZHOU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHUJIE","family":"XIA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUE","family":"CHENG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,2,16]]},"reference":[{"key":"key20180107212946_b1-or-33-04-1791","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"key20180107212946_b2-or-33-04-1791","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.juro.2006.09.027","article-title":"Defining optimal therapy for muscle invasive bladder cancer","volume":"177","author":"Herr","year":"2007","journal-title":"J Urol"},{"key":"key20180107212946_b3-or-33-04-1791","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.eururo.2007.03.016","article-title":"Long-term survival after gemcitabine and cisplatin in patients with locally advanced transitional cell carcinoma of the bladder: focus on supplementary treatment strategies","volume":"52","author":"Als","year":"2007","journal-title":"Eur Urol"},{"key":"key20180107212946_b4-or-33-04-1791","doi-asserted-by":"crossref","first-page":"201367","DOI":"10.4061\/2010\/201367","article-title":"Cellular responses to cisplatin-induced DNA damage","volume":"2010","author":"Basu","year":"2010","journal-title":"J Nucleic Acids"},{"key":"key20180107212946_b5-or-33-04-1791","first-page":"547","article-title":"Membrane transporters as mediators of cisplatin side-effects","volume":"34","author":"Ciarimboli","year":"2014","journal-title":"Anticancer Res"},{"key":"key20180107212946_b6-or-33-04-1791","first-page":"1421","article-title":"\u03b2-Elemene promotes cisplatin-induced cell death in human bladder cancer and other carcinomas","volume":"33","author":"Li","year":"2013","journal-title":"Anticancer Res"},{"key":"key20180107212946_b7-or-33-04-1791","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/jjco\/hym035","article-title":"Genes regulating the sensitivity of solid tumor cell lines to cytotoxic agents: a literature review","volume":"37","author":"Sekine","year":"2007","journal-title":"Jpn J Clin Oncol"},{"key":"key20180107212946_b8-or-33-04-1791","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1006\/bbrc.2001.5092","article-title":"Cloning, characterization, and expression of human LIG1","volume":"284","author":"Nilsson","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107212946_b9-or-33-04-1791","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1080\/028418602760169398","article-title":"Is LRIG1 a tumour suppressor gene at chromosome 3p14.3?","volume":"41","author":"Hedman","year":"2002","journal-title":"Acta Oncol"},{"key":"key20180107212946_b10-or-33-04-1791","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1464-410X.2006.06405.x","article-title":"LRIG1, a candidate tumour-suppressor gene in human bladder cancer cell line BIU87","volume":"98","author":"Yang","year":"2006","journal-title":"BJU Int"},{"key":"key20180107212946_b11-or-33-04-1791","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.ejca.2006.10.021","article-title":"LRIG inhibitors of growth factor signalling - double-edged swords in human cancer?","volume":"43","author":"Hedman","year":"2007","journal-title":"Eur J Cancer"},{"key":"key20180107212946_b12-or-33-04-1791","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1038\/sj.emboj.7600342","article-title":"LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation","volume":"23","author":"Gur","year":"2004","journal-title":"EMBO J"},{"key":"key20180107212946_b13-or-33-04-1791","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0959-8049(01)00230-1","article-title":"The EGFR family and its ligands in human cancer: signalling mechanisms and therapeutic opportunities","volume":"37","author":"Yarden","year":"2001","journal-title":"Eur J Cancer"},{"key":"key20180107212946_b14-or-33-04-1791","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1023\/A:1011177318162","article-title":"The type III epidermal growth factor receptor mutation. Biological significance and potential target for anti-cancer therapy","volume":"12","author":"Pedersen","year":"2001","journal-title":"Ann Oncol"},{"key":"key20180107212946_b15-or-33-04-1791","first-page":"120","article-title":"The complexity of targeting EGFR signalling in cancer: from expression to turnover","volume":"1766","author":"Sebastian","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"key20180107212946_b16-or-33-04-1791","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/annonc\/mdu037","article-title":"S100A9 and EGFR gene signatures predict disease progression in muscle invasive bladder cancer patients after chemotherapy","volume":"25","author":"Kim","year":"2014","journal-title":"Ann Oncol"},{"key":"key20180107212946_b17-or-33-04-1791","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s12253-008-9020-5","article-title":"EGFR inhibitor enhances cisplatin sensitivity of oral squamous cell carcinoma cell lines","volume":"14","author":"Hiraishi","year":"2008","journal-title":"Pathol Oncol Res"},{"key":"key20180107212946_b18-or-33-04-1791","first-page":"1629","article-title":"LRIG1 combined with cisplatin enhances bladder cancer lesions via a novel pathway","volume":"25","author":"Li","year":"2011","journal-title":"Oncol Rep"},{"key":"key20180107212946_b19-or-33-04-1791","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc2167","article-title":"The resurgence of platinum-based cancer chemotherapy","volume":"7","author":"Kelland","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"key20180107212946_b20-or-33-04-1791","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1016\/j.biomaterials.2009.05.035","article-title":"A chitosan hydrogel delivery system for osteosarcoma gene therapy with pigment epithelium-derived factor combined with chemotherapy","volume":"30","author":"Ta","year":"2009","journal-title":"Biomaterials"},{"key":"key20180107212946_b21-or-33-04-1791","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s11596-011-0675-x","article-title":"EGFR inhibitor enhances cisplatin sensitivity of human glioma cells","volume":"31","author":"Zhang","year":"2011","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"key20180107212946_b22-or-33-04-1791","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1016\/j.febslet.2008.11.010","article-title":"The anti-EGFR monoclonal antibody blocks cisplatin-induced activation of EGFR signaling mediated by HB-EGF","volume":"582","author":"Yoshida","year":"2008","journal-title":"FEBS Lett"},{"key":"key20180107212946_b23-or-33-04-1791","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1002\/jbm.a.34207","article-title":"Synthesis and characterization of cisplatin-loaded, EGFR-targeted biopolymer and in vitro evaluation for targeted delivery","volume":"100","author":"Geng","year":"2012","journal-title":"J Biomed Mater Res A"},{"key":"key20180107212946_b24-or-33-04-1791","doi-asserted-by":"crossref","first-page":"R49","DOI":"10.1186\/bcr2103","article-title":"Expression of the epidermal growth factor receptor (EGFR) and the phosphorylated EGFR in invasive breast carcinomas","volume":"10","author":"Magkou","year":"2008","journal-title":"Breast Cancer Res"},{"key":"key20180107212946_b25-or-33-04-1791","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1073\/pnas.96.4.1415","article-title":"Mechanism of biological synergy between cellular Src and epidermal growth factor receptor","volume":"96","author":"Tice","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107212946_b26-or-33-04-1791","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/onc.2013.98","article-title":"LRIG1 modulates aggressiveness of head and neck cancers by regulating EGFR-MAPK-SPHK1 signaling and extracellular matrix remodeling","volume":"33","author":"Sheu","year":"2014","journal-title":"Oncogene"},{"key":"key20180107212946_b27-or-33-04-1791","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0014-5793(02)02824-7","article-title":"Targeted disruption of LIG-1 gene results in psoriasiform epidermal hyperplasia","volume":"521","author":"Suzuki","year":"2002","journal-title":"FEBS Lett"},{"key":"key20180107212946_b28-or-33-04-1791","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.3349\/ymj.2014.55.5.1196","article-title":"LRIG1 enhances chemosensitivity by modulating BCL-2 expression and receptor tyrosine kinase signaling in glioma cells","volume":"55","author":"Guo","year":"2014","journal-title":"Yonsei Med J"},{"key":"key20180107212946_b29-or-33-04-1791","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/0092-8674(93)90457-2","article-title":"Molecular regulation of apoptosis: genetic controls on cell death","volume":"74","author":"Williams","year":"1993","journal-title":"Cell"},{"key":"key20180107212946_b30-or-33-04-1791","first-page":"1229","article-title":"Tetrocarcin A inhibits mitochondrial functions of Bcl-2 and suppresses its anti-apoptotic activity","volume":"60","author":"Nakashima","year":"2000","journal-title":"Cancer Res"},{"key":"key20180107212946_b31-or-33-04-1791","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1101\/gad.13.15.1899","article-title":"BCL-2 family members and the mitochondria in apoptosis","volume":"13","author":"Gross","year":"1999","journal-title":"Genes Dev"},{"key":"key20180107212946_b32-or-33-04-1791","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/sj.onc.1210220","article-title":"The Bcl-2 apoptotic switch in cancer development and therapy","volume":"26","author":"Adams","year":"2007","journal-title":"Oncogene"},{"key":"key20180107212946_b33-or-33-04-1791","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.regpep.2012.02.003","article-title":"RNAi knockdown of the Akt1 gene increases the chemosensitivity of gastric cancer cells to cisplatin both in vitro and in vivo","volume":"176","author":"Zhou","year":"2012","journal-title":"Regul Pept"},{"key":"key20180107212946_b34-or-33-04-1791","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s10495-010-0489-5","article-title":"Recombinant human PDCD5 sensitizes chondrosarcomas to cisplatin chemotherapy in vitro and in vivo","volume":"15","author":"Chen","year":"2010","journal-title":"Apoptosis"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2015.3807\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T16:30:00Z","timestamp":1515342600000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2015.3807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,16]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,2,16]]},"published-print":{"date-parts":[[2015,4]]}},"alternative-id":["10.3892\/or.2015.3807"],"URL":"https:\/\/doi.org\/10.3892\/or.2015.3807","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,16]]}}}